Sign inJoin free

Watch / Buy, Hold or Sell?

Never too much information: TMS on FPH & AD8

6 Apr 202211:16

Never too much information: TMS on FPH & AD8

General information only. ausbiz videos are general information only, produced by Ausbiz TV Pty Ltd, a media business that doesn’t give financial advice. They don’t take into account your objectives, financial situation or needs. Consider whether it’s right for you and read the PDS and TMD before acting on anything you watch.

About this video

Ben Clark is adding to TMS Capital's position in Audinate (AD8) a company that stands to benefit from the reopening, and which is battered and bruised as bond yields rise and markets adjust to the rising interest rate environment. Fisher & Paykel (FPH) may not be in 'buy' territory today, but it is a solid 'hold'...listen for why. Ben's stock recommendations comes on a day Australian shares slipped on as energy stocks tracked a tumble in oil prices and the technology sector witnessed a sell-off, with sentiment dented further by renewed fears of a potentially faster global interest-rate hike cycle. S&P/ASX 200 index finished down 0.5% at 7,490. Local tech shares fell as much as 3.4%, tracking growth stocks on Wall Street lower after Federal Reserve Governor Lael Brainard spooked investors about potential aggressive actions by the central bank to control inflation. Energy stocks fell 1.5% following a drop in the oil futures overnight after data showed that a build in U.S. crude stocks and Shanghai's extended lockdown fueled fears of slower demand. Australian in vitro fertilization (IVF) service provider Virtus Health (VRT) was up 0.7% on receiving a revised A$8 per share buyout offer from private equity firm BGH Capital. New Zealand's benchmark S&P/NZX 50 fell 0.51% to 12,059 points.

More like this

We value your privacy

We use essential cookies to make the site work. Non-essential cookies help us improve the experience. You can accept or reject non-essential cookies. Privacy policy